Phathom Pharmaceuticals

Price & Volume

Stats

52W Range	$6.06-$19.71
Market Cap	$596.9M
Shares Short	17M

Financials

Revenue (12 Mos)	$26.2M
Revenue Growth (YoY)	0%
Gross Profit (12 Mos)	$0
Diluted EPS	-$5.74

News

Yahoo Finance • 11 months ago

Phathom Pharmaceuticals Announces Expansion of Existing Loan and Security Agreement with Hercules Capital

Yahoo Finance • 12 months ago

Phathom Pharmaceuticals Announces Commercial Availability of VOQUEZNA® (vonoprazan) Tablets, a Powerful First-In-Class PCAB for the Treatment of Erosive GERD and Relief of Associated Heartburn

Yahoo Finance • last year

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of Phathom Pharmaceuticals, Inc. (NASDAQ: PHAT)

Yahoo Finance • last year

SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of Phathom Pharmaceuticals, Inc. (NASDAQ: PHAT) and Encourages Investors to Contact the Firm

About

CEO	Ms. Terrie J. Curran
Address	100 Campus Drive, Florham Park, NJ, United States, 07932
Sector	Healthcare
Industry	Biotechnology
Full-Time Employees	452